These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3109094)

  • 21. Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis.
    Kyung YS; Park HY; Lee G
    Arch Toxicol; 2011 Jan; 85(1):51-7. PubMed ID: 20186394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N; Pohl J; Stekar J
    J Cancer Res Clin Oncol; 1981; 100(3):311-20. PubMed ID: 6792207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Yildirim I; Korkmaz A; Oter S; Ozcan A; Oztas E
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
    Grañena A; Gardella S; Marín P; Carreras E; Montserrat E; Rozman C
    Sangre (Barc); 1986; 31(3):307-10. PubMed ID: 3092373
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesnum and cyclophosphamide cystitis.
    Lancet; 1980 Nov; 2(8205):1195. PubMed ID: 6107795
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice.
    Song J; Liu L; Li L; Liu J; Song E; Song Y
    Cell Biochem Funct; 2014 Mar; 32(2):125-32. PubMed ID: 23650119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
    Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.
    Haselberger MB; Schwinghammer TL
    Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.
    Blacklock H; Ball L; Knight C; Schey S; Prentice G
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():45-52. PubMed ID: 6414695
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ifosfamide-induced urinary bladder lesion and its inhibition by mesna].
    Muraoka Y; Watanabe H; Matsui S; Nara H; Kasai H
    Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):73-83. PubMed ID: 2121633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N; Pohl J
    IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mesna on cyclophosphamide.
    Garrick CL; Cronin SM; Sensenbrenner LL
    DICP; 1989 Oct; 23(10):798-9. PubMed ID: 2510409
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD; Pringle LE; Barnett MJ; Klingemann HG; Reece DE; Phillips GL
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
    Czownicki Z; Utracka-Hutka B
    Nowotwory; 1981; 30(4):377-83. PubMed ID: 6792599
    [No Abstract]   [Full Text] [Related]  

  • 38. The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities.
    Menétrey D; Bon K; Michiels JF; Lantéri-Minet M
    C R Acad Sci III; 1999 Jun; 322(6):505-15. PubMed ID: 10457601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of cyclophosphamide and its uroprotective agents, mesna and hyperbaric oxygen, on urinary bladder motility in guinea pigs.
    Sağmanligil V; Etlik O; Pişkin I; Tomur A
    Acta Vet Hung; 1999; 47(4):451-60. PubMed ID: 10641335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants.
    Nicolau DP; Hogan KR
    Mayo Clin Proc; 1992 Jun; 67(6):611-2. PubMed ID: 1434892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.